Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

CDIB Capital

Investor type Private Equity Firm


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 37
Average round size
The average size of a deal this fund participated in
Portfolio companies 32
Rounds per year 2.31
Lead investments 6
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 4
Key employees 3
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Information Technology
  • Health Care
  • Biotechnology
  • Artificial Intelligence
  • E-Commerce

CDIB Capital is the famous VC, which was founded in 2006. The fund was located in Asia if to be more exact in Hong Kong. The leading representative office of defined VC is situated in the Hong Kong.

Among the various public portfolio startups of the fund, we may underline CrownBio, Citiesocial, iCHEF The fund has no exact preference in some founders of portfolio startups. In case when startup counts 3 of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Robotics, Apps. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Taiwan.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the CDIB Capital, startups are often financed by Qiming Venture Partners, GGV Capital, Alibaba Entrepreneurs Fund. The meaningful sponsors for the fund in investment in the same round are Alibaba Entrepreneurs Fund, Qiming Venture Partners, Thundersoft. In the next rounds fund is usually obtained by Qiming Venture Partners, Alibaba Entrepreneurs Fund, Star Ventures.

The overall number of key employees were 3.

Considering the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 investment rounds annually. Opposing the other organizations, this CDIB Capital works on 18 percentage points less the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The average startup value when the investment from CDIB Capital is 500 millions - 1 billion dollars. The increased amount of exits for fund were in 2017.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of CDIB Capital:
Typical Co-investors
CDIB Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after CDIB Capital:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Astral Friends & Fam -
CanLab Germany, Leipzig, Saxony
Dhabi Holdings Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
Edson Student Entrepreneur Initiative Arizona, Scottsdale, United States
Ekstranda Ösby, Sodermanlands Lan, Sweden
eLab Ventures Ann Arbor, Michigan, United States
FINTECH Circle England, London, United Kingdom
Serena France, Ile-de-France, Paris
Tech Nation Fintech England, London, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Micronbrane Medical

Health Care
Medical Device
$4M28 Sep 2022 Taoyüan, Taitung County, Taiwan


Artificial Intelligence
Health Care
Machine Learning
Medical Device
$110M16 Jun 2022 Tel Aviv-Yafo, Tel Aviv District, Israel


Language Learning
$15M16 Feb 2022 Taipei, Taiwan

InstaDeep Ltd

Artificial Intelligence
$100M25 Jan 2022 London, England, United Kingdom


Mobile Apps
$15M08 Nov 2021 New Taipei, Taiwan

UnaBiz Holdings Pte Ltd

Internet of Things
Network Security
$25M11 Oct 2021 Singapore, Central, Singapore


Financial Services
Information Technology
$17M20 Apr 2021 New Taipei, Taiwan


Health Care
$47M16 Mar 2021 Vallejo, California, United States


Artificial Intelligence
Information Technology
Internet of Things
Machine Learning
$10M30 Sep 2020 New Taipei, Taiwan


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent CDIB Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: